IQVIA Announces Repurchase of Common Stock
February 13 2020 - 3:41PM
Business Wire
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that it
has agreed to purchase an aggregate of 1,000,000 shares (the
“Shares”) of its common stock in a private transaction from certain
of its existing stockholders (the “Repurchase”). In addition to the
Repurchase, affiliates of TPG Global, LLC, investment funds
associated with Bain Capital Investors, LLC and CPP Investment
Board Private Holdings Inc. informed IQVIA that they have sold
4,000,000 shares of IQVIA’s common stock pursuant to Rule 144 under
the Securities Act of 1933, as amended, for a total of 5,000,000
shares.
IQVIA expects to fund the Repurchase with cash on hand and
borrowings from its revolving credit facility. The Repurchase is
being conducted under IQVIA’s existing stock repurchase
authorization.
Certain statements in this press release are forward-looking
statements. These statements involve a number of risks,
uncertainties and other factors, including the failure to
consummate the purchase of the Shares.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions and contract research services to
the life sciences industry. Formed through the merger of IMS Health
and Quintiles, IQVIA applies human data science — leveraging the
analytic rigor and clarity of data science to the ever-expanding
scope of human science — to enable companies to reimagine and
develop new approaches to clinical development and
commercialization, speed innovation, and accelerate improvements in
healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers
unique and actionable insights at the intersection of large-scale
analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With approximately
67,000 employees, IQVIA conducts operations in more than 100
countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
Click here to subscribe to Mobile Alerts for IQVIA.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200213005931/en/
IQVIA Holdings Inc. Investor Relations: Andrew Markwick,
973-257-7144 andrew.markwick@iqvia.com or Media Relations: Tor
Constantino, 484-567-6732 tor.constantino@iqvia.com
IQVIA (NYSE:IQV)
Historical Stock Chart
From Apr 2024 to May 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From May 2023 to May 2024